Cargando…

Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study

BACKGROUND: Regular repeat surveillance testing is a strategy to identify asymptomatic individuals with SARS-CoV-2 infections in high-risk work settings to prevent onward community transmission. Saliva sampling is less invasive compared to nasal/oropharyngeal sampling, thus making it suitable for re...

Descripción completa

Detalles Bibliográficos
Autores principales: Jenney, Adam, Chibo, Doris, Batty, Mitch, Druce, Julian, Melvin, Robert, Stewardson, Andrew, Dennison, Amanda, Symes, Sally, Kinsella, Paul, Tran, Thomas, Mackenzie, Charlene, Johnson, Douglas, Thevarajan, Irani, McGrath, Christian, Matlock, Amelia, Prestedge, Jacqueline, Gooey, Megan, Roney, Janine, Bobbitt, Joanne, Yallop, Sarah, Catton, Mike, Williamson, Deborah A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263280/
https://www.ncbi.nlm.nih.gov/pubmed/35821908
http://dx.doi.org/10.1016/j.lanwpc.2022.100533
_version_ 1784742698038591488
author Jenney, Adam
Chibo, Doris
Batty, Mitch
Druce, Julian
Melvin, Robert
Stewardson, Andrew
Dennison, Amanda
Symes, Sally
Kinsella, Paul
Tran, Thomas
Mackenzie, Charlene
Johnson, Douglas
Thevarajan, Irani
McGrath, Christian
Matlock, Amelia
Prestedge, Jacqueline
Gooey, Megan
Roney, Janine
Bobbitt, Joanne
Yallop, Sarah
Catton, Mike
Williamson, Deborah A
author_facet Jenney, Adam
Chibo, Doris
Batty, Mitch
Druce, Julian
Melvin, Robert
Stewardson, Andrew
Dennison, Amanda
Symes, Sally
Kinsella, Paul
Tran, Thomas
Mackenzie, Charlene
Johnson, Douglas
Thevarajan, Irani
McGrath, Christian
Matlock, Amelia
Prestedge, Jacqueline
Gooey, Megan
Roney, Janine
Bobbitt, Joanne
Yallop, Sarah
Catton, Mike
Williamson, Deborah A
author_sort Jenney, Adam
collection PubMed
description BACKGROUND: Regular repeat surveillance testing is a strategy to identify asymptomatic individuals with SARS-CoV-2 infections in high-risk work settings to prevent onward community transmission. Saliva sampling is less invasive compared to nasal/oropharyngeal sampling, thus making it suitable for regular testing. In this multi-centre evaluation, we aimed to validate RT-PCR using salivary swab testing of SARS-CoV-2 for large-scale surveillance testing and assess implementation amongst staff working in the hotel quarantine system in Victoria, Australia. METHODS: A multi-centre laboratory evaluation study was conducted to systematically validate the in vitro and clinical performance of salivary swab RT-PCR for implementation of SARS-CoV-2 surveillance testing. Analytical sensitivity for multiple RT-PCR platforms was assessed using a dilution series of known SARS-CoV-2 viral loads, and assay specificity was examined using a panel of viral pathogens other than SARS-CoV-2. In addition, we tested capacity for large-scale saliva testing using a four-sample pooling approach, where positive pools were subsequently decoupled and retested. Regular, frequent self-collected saliva swab RT-PCR testing was implemented for staff across fourteen quarantine hotels. Samples were tested at three diagnostic laboratories validated in this study, and results were provided back to staff in real-time. FINDINGS: The agreement of self-collected saliva swabs for RT-PCR was 84.5% (95% CI 68.6 to 93.8) compared to RT-PCR using nasal/oropharyngeal swab samples collected by a healthcare practitioner, when saliva samples were collected within seven days of symptom onset. Between 7th December 2020 and 17th December 2021, almost 500,000 RT-PCR tests were performed on saliva swabs self-collected by 102 staff working in quarantine hotels in Melbourne. Of these, 20 positive saliva swabs were produced by 13 staff (0.004%). The majority of staff that tested positive occurred during periods of community transmission of the SARS-CoV-2 Delta variant. INTERPRETATION: Salivary RT-PCR had an acceptable level of agreement compared to standard nasal/oropharyngeal swab RT-PCR within early symptom onset. The scalability, tolerability and ease of self-collection highlights utility for frequent or repeated testing in high-risk settings, such as quarantine or healthcare environments where regular monitoring of staff is critical for public health, and protection of vulnerable populations. FUNDING: This work was funded by the Victorian Department of Health.
format Online
Article
Text
id pubmed-9263280
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92632802022-07-08 Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study Jenney, Adam Chibo, Doris Batty, Mitch Druce, Julian Melvin, Robert Stewardson, Andrew Dennison, Amanda Symes, Sally Kinsella, Paul Tran, Thomas Mackenzie, Charlene Johnson, Douglas Thevarajan, Irani McGrath, Christian Matlock, Amelia Prestedge, Jacqueline Gooey, Megan Roney, Janine Bobbitt, Joanne Yallop, Sarah Catton, Mike Williamson, Deborah A Lancet Reg Health West Pac Articles BACKGROUND: Regular repeat surveillance testing is a strategy to identify asymptomatic individuals with SARS-CoV-2 infections in high-risk work settings to prevent onward community transmission. Saliva sampling is less invasive compared to nasal/oropharyngeal sampling, thus making it suitable for regular testing. In this multi-centre evaluation, we aimed to validate RT-PCR using salivary swab testing of SARS-CoV-2 for large-scale surveillance testing and assess implementation amongst staff working in the hotel quarantine system in Victoria, Australia. METHODS: A multi-centre laboratory evaluation study was conducted to systematically validate the in vitro and clinical performance of salivary swab RT-PCR for implementation of SARS-CoV-2 surveillance testing. Analytical sensitivity for multiple RT-PCR platforms was assessed using a dilution series of known SARS-CoV-2 viral loads, and assay specificity was examined using a panel of viral pathogens other than SARS-CoV-2. In addition, we tested capacity for large-scale saliva testing using a four-sample pooling approach, where positive pools were subsequently decoupled and retested. Regular, frequent self-collected saliva swab RT-PCR testing was implemented for staff across fourteen quarantine hotels. Samples were tested at three diagnostic laboratories validated in this study, and results were provided back to staff in real-time. FINDINGS: The agreement of self-collected saliva swabs for RT-PCR was 84.5% (95% CI 68.6 to 93.8) compared to RT-PCR using nasal/oropharyngeal swab samples collected by a healthcare practitioner, when saliva samples were collected within seven days of symptom onset. Between 7th December 2020 and 17th December 2021, almost 500,000 RT-PCR tests were performed on saliva swabs self-collected by 102 staff working in quarantine hotels in Melbourne. Of these, 20 positive saliva swabs were produced by 13 staff (0.004%). The majority of staff that tested positive occurred during periods of community transmission of the SARS-CoV-2 Delta variant. INTERPRETATION: Salivary RT-PCR had an acceptable level of agreement compared to standard nasal/oropharyngeal swab RT-PCR within early symptom onset. The scalability, tolerability and ease of self-collection highlights utility for frequent or repeated testing in high-risk settings, such as quarantine or healthcare environments where regular monitoring of staff is critical for public health, and protection of vulnerable populations. FUNDING: This work was funded by the Victorian Department of Health. Elsevier 2022-07-08 /pmc/articles/PMC9263280/ /pubmed/35821908 http://dx.doi.org/10.1016/j.lanwpc.2022.100533 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Jenney, Adam
Chibo, Doris
Batty, Mitch
Druce, Julian
Melvin, Robert
Stewardson, Andrew
Dennison, Amanda
Symes, Sally
Kinsella, Paul
Tran, Thomas
Mackenzie, Charlene
Johnson, Douglas
Thevarajan, Irani
McGrath, Christian
Matlock, Amelia
Prestedge, Jacqueline
Gooey, Megan
Roney, Janine
Bobbitt, Joanne
Yallop, Sarah
Catton, Mike
Williamson, Deborah A
Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study
title Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study
title_full Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study
title_fullStr Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study
title_full_unstemmed Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study
title_short Surveillance testing using salivary RT-PCR for SARS-CoV-2 in managed quarantine facilities in Australia: A laboratory validation and implementation study
title_sort surveillance testing using salivary rt-pcr for sars-cov-2 in managed quarantine facilities in australia: a laboratory validation and implementation study
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263280/
https://www.ncbi.nlm.nih.gov/pubmed/35821908
http://dx.doi.org/10.1016/j.lanwpc.2022.100533
work_keys_str_mv AT jenneyadam surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT chibodoris surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT battymitch surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT drucejulian surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT melvinrobert surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT stewardsonandrew surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT dennisonamanda surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT symessally surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT kinsellapaul surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT tranthomas surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT mackenziecharlene surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT johnsondouglas surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT thevarajanirani surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT mcgrathchristian surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT matlockamelia surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT prestedgejacqueline surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT gooeymegan surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT roneyjanine surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT bobbittjoanne surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT yallopsarah surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT cattonmike surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy
AT williamsondeboraha surveillancetestingusingsalivaryrtpcrforsarscov2inmanagedquarantinefacilitiesinaustraliaalaboratoryvalidationandimplementationstudy